Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
Clinical trial NCT01358071 · COMPLETED
Trial details
- NCT number
- NCT01358071
- Sponsor
- AGC Biologics S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.